50.25% of Maravai LifeSciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Maravai LifeSciences Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2024	Braidwell LP	8,353,287	$69.42M	2.0%	-7.4%	3.312%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	205,760	$1.71M	0.0%	-12.2%	0.082%
11/14/2024	MetLife Investment Management LLC	64,736	$0.54M	0.0%	+129.1%	0.026%
11/13/2024	Glenmede Trust Co. NA	2,226,034	$18.50M	0.1%	-1.4%	0.883%
11/13/2024	Quantbot Technologies LP	7,432	$62K	0.0%	-54.6%	0.003%
11/13/2024	FMR LLC	2,479,235	$20.60M	0.0%	-6.0%	0.983%
11/13/2024	The Manufacturers Life Insurance Company	58,987	$0.49M	0.0%	+36.0%	0.023%
11/12/2024	Algert Global LLC	101,718	$0.85M	0.0%	-32.6%	0.040%
11/12/2024	Charles Schwab Investment Management Inc.	946,576	$7.87M	0.0%	+6.3%	0.375%
11/12/2024	Massachusetts Financial Services Co. MA	3,601,725	$29.93M	0.0%	-20.8%	1.428%
11/9/2024	Intech Investment Management LLC	24,012	$0.20M	0.0%	N/A	0.010%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	390,267	$3.24M	0.0%	-13.4%	0.155%
11/8/2024	Jennison Associates LLC	2,980,645	$24.77M	0.0%	-34.6%	1.182%
11/7/2024	Thrivent Financial for Lutherans	214,645	$1.78M	0.0%	+14.3%	0.085%
11/6/2024	Royce & Associates LP	908,778	$7.55M	0.1%	+130.4%	0.360%
11/6/2024	Sivik Global Healthcare LLC	425,000	$3.53M	1.5%	-5.6%	0.168%
11/5/2024	Victory Capital Management Inc.	58,327	$0.49M	0.0%	+312.3%	0.023%
11/4/2024	Venturi Wealth Management LLC	5,705	$47K	0.0%	N/A	0.002%
10/31/2024	Kornitzer Capital Management Inc. KS	519,890	$4.32M	0.1%	+0.7%	0.206%
10/31/2024	Principal Financial Group Inc.	352,600	$2.93M	0.0%	-47.1%	0.140%
10/29/2024	Cannon Global Investment Management LLC	71,000	$0.59M	0.9%	N/A	0.028%
10/25/2024	Roubaix Capital LLC	237,747	$1.98M	1.1%	-45.5%	0.094%
10/25/2024	China Universal Asset Management Co. Ltd.	27,225	$0.23M	0.0%	+74.5%	0.011%
10/24/2024	Custom Index Systems LLC	11,686	$97K	0.1%	N/A	0.005%
10/23/2024	E. Ohman J or Asset Management AB	232,751	$1.93M	0.0%	+28.8%	0.092%
10/18/2024	Blue Trust Inc.	17,409	$0.15M	0.0%	+181.1%	0.007%
10/16/2024	Bleakley Financial Group LLC	32,034	$0.27M	0.0%	+38.3%	0.013%
10/11/2024	Creative Planning	44,943	$0.37M	0.0%	+4.4%	0.018%
10/5/2024	Handelsbanken Fonder AB	44,600	$0.37M	0.0%	+35.6%	0.018%
10/3/2024	SG Americas Securities LLC	30,807	$0.26M	0.0%	N/A	0.012%
9/16/2024	Point72 Asia Singapore Pte. Ltd.	4,449	$32K	0.0%	N/A	0.002%
8/27/2024	Clearbridge Investments LLC	1,054,109	$7.55M	0.0%	+31.7%	0.418%
8/16/2024	Systematic Financial Management LP	1,405,662	$10.07M	0.3%	-6.6%	0.558%
8/16/2024	Algert Global LLC	150,878	$1.08M	0.0%	N/A	0.060%
8/15/2024	Mackenzie Financial Corp	5,860,641	$41.96M	0.1%	+16.8%	2.326%
8/15/2024	The Manufacturers Life Insurance Company	43,372	$0.31M	0.0%	N/A	0.017%
8/15/2024	Millennium Management LLC	5,968,592	$42.74M	0.0%	+12.3%	2.369%
8/15/2024	Dragoneer Investment Group LLC	750,468	$5.37M	0.1%	N/A	0.298%
8/15/2024	AQR Capital Management LLC	773,013	$5.54M	0.0%	-72.6%	0.307%
8/15/2024	Alpha DNA Investment Management LLC	57,037	$0.41M	0.2%	N/A	0.023%
8/15/2024	Point72 Asia Singapore Pte. Ltd.	4,449	$32K	0.0%	N/A	0.002%
8/15/2024	Point72 Europe London LLP	2,468,465	$17.67M	1.5%	+12.2%	0.980%
8/14/2024	Squarepoint Ops LLC	355,590	$2.55M	0.0%	+181.8%	0.141%
8/14/2024	Point72 Asset Management L.P.	3,519,561	$25.20M	0.1%	+149.6%	1.397%
8/14/2024	Cubist Systematic Strategies LLC	284,146	$2.03M	0.0%	-21.1%	0.113%
8/14/2024	Marshall Wace LLP	4,004,884	$28.68M	0.0%	-17.1%	1.590%
8/14/2024	Epoch Investment Partners Inc.	101,308	$0.73M	0.0%	-63.7%	0.040%
8/14/2024	Frank Rimerman Advisors LLC	55,668	$0.40M	0.0%	N/A	0.022%
8/13/2024	Symmetry Investments LP	115,000	$0.82M	0.1%	N/A	0.046%
8/13/2024	Ensign Peak Advisors Inc	37,150	$0.27M	0.0%	N/A	0.015%
8/13/2024	Thrivent Financial for Lutherans	187,760	$1.34M	0.0%	+6.8%	0.075%
8/13/2024	Sei Investments Co.	20,670	$0.15M	0.0%	-68.8%	0.008%
8/13/2024	Granite Investment Partners LLC	999,159	$7.15M	0.3%	-11.1%	0.397%
8/12/2024	Seven Eight Capital LP	14,712	$0.11M	0.0%	-75.5%	0.006%
8/12/2024	Blair William & Co. IL	95,618	$0.69M	0.0%	-3.2%	0.038%
8/12/2024	Amalgamated Bank	3,871	$28K	0.0%	-82.3%	0.002%
8/9/2024	Gtcr LLC	20,150,005	$144.27M	12.5%	-7.1%	7.998%
8/9/2024	Renaissance Technologies LLC	3,881,441	$27.79M	0.0%	+20.8%	1.541%
8/9/2024	Dimensional Fund Advisors LP	658,397	$4.71M	0.0%	-18.1%	0.261%
8/9/2024	Massachusetts Financial Services Co. MA	4,550,503	$32.58M	0.0%	+15.1%	1.806%
8/7/2024	Pier Capital LLC	478,355	$3.43M	0.5%	-5.5%	0.190%
8/7/2024	Headlands Technologies LLC	14,935	$0.11M	0.0%	+205.9%	0.006%
8/7/2024	Monaco Asset Management SAM	200,000	$1.43M	0.2%	+26.5%	0.079%
8/7/2024	Choreo LLC	67,310	$0.47M	0.0%	N/A	0.027%
8/5/2024	Victory Capital Management Inc.	14,147	$0.10M	0.0%	-57.6%	0.006%
8/5/2024	VELA Investment Management LLC	95,866	$0.69M	0.2%	+29.0%	0.038%
8/2/2024	Roubaix Capital LLC	436,218	$3.12M	2.0%	N/A	0.173%
8/1/2024	Rhumbline Advisers	171,489	$1.23M	0.0%	+30.4%	0.068%
7/30/2024	Sivik Global Healthcare LLC	450,000	$3.22M	1.2%	+23.3%	0.179%
7/29/2024	Principal Financial Group Inc.	666,187	$4.77M	0.0%	+62.4%	0.264%
7/29/2024	Panagora Asset Management Inc.	11,507	$82K	0.0%	-57.0%	0.005%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	25,450	$0.18M	0.0%	+32.3%	0.010%
7/26/2024	Liontrust Investment Partners LLP	43,845	$0.31M	0.0%	+14.7%	0.017%
7/26/2024	Bank of New York Mellon Corp	506,413	$3.63M	0.0%	+30.1%	0.201%
7/18/2024	Blue Trust Inc.	6,194	$44K	0.0%	N/A	0.002%
7/16/2024	Wedmont Private Capital	38,507	$0.28M	0.0%	-9.3%	0.015%
7/10/2024	Simplicity Wealth LLC	23,131	$0.17M	0.0%	-21.9%	0.009%
7/2/2024	GAMMA Investing LLC	3,585	$26K	0.0%	+310.2%	0.001%
5/16/2024	California State Teachers Retirement System	112,186	$0.97M	0.0%	-5.1%	0.045%
5/16/2024	Jacobs Levy Equity Management Inc.	57,076	$0.50M	0.0%	-66.8%	0.023%
5/16/2024	Janus Henderson Group PLC	49,063	$0.43M	0.0%	-89.3%	0.020%
5/16/2024	Kennedy Capital Management LLC	97,277	$0.84M	0.0%	-7.0%	0.039%
5/16/2024	Bayesian Capital Management LP	74,175	$0.64M	0.1%	N/A	0.030%
5/15/2024	Public Employees Retirement System of Ohio	42,039	$0.36M	0.0%	-8.6%	0.017%
5/15/2024	Bamco Inc. NY	2,123,651	$18.41M	0.0%	+43.1%	0.845%
5/15/2024	Price T Rowe Associates Inc. MD	73,595	$0.64M	0.0%	+5.1%	0.029%
5/15/2024	Lazard Asset Management LLC	365,159	$3.17M	0.0%	+6,252.8%	0.145%
5/15/2024	Epoch Investment Partners Inc.	279,432	$2.42M	0.0%	-79.8%	0.111%
5/14/2024	Delap Wealth Advisory LLC	12,207	$0.11M	0.0%	N/A	0.005%
5/13/2024	Clearbridge Investments LLC	800,222	$6.94M	0.0%	+2.7%	0.318%
5/13/2024	Seven Eight Capital LP	60,053	$0.52M	0.1%	N/A	0.024%
5/10/2024	Vanguard Group Inc.	10,038,126	$87.03M	0.0%	+0.3%	3.993%
5/9/2024	Orion Portfolio Solutions LLC	115,239	$1M	0.0%	+14.4%	0.046%
5/9/2024	Blair William & Co. IL	98,774	$0.86M	0.0%	-2.2%	0.039%
5/9/2024	Monaco Asset Management SAM	158,151	$1.37M	0.4%	-49.2%	0.063%
5/9/2024	Mitsubishi UFJ Asset Management Co. Ltd.	47,667	$0.41M	0.0%	-4.4%	0.019%
5/8/2024	Bleakley Financial Group LLC	29,613	$0.26M	0.0%	+24.6%	0.012%
5/8/2024	Russell Investments Group Ltd.	13,181	$0.11M	0.0%	-88.3%	0.005%
5/8/2024	QRG Capital Management Inc.	17,143	$0.15M	0.0%	+11.7%	0.007%
5/8/2024	Headlands Technologies LLC	4,882	$42K	0.0%	N/A	0.002%

Data available starting January 2016

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.

Today's Range

Now: $5.20

$5.13

$5.56

50 Day Range

MA: $7.92

$5.08

$9.24

52 Week Range

Now: $5.20

$4.68

$11.56

Volume

2,294,593 shs

Average Volume

2,264,957 shs

Market Capitalization

$1.31 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.02

Who are the company insiders with the largest holdings of Maravai LifeSciences?: Maravai LifeSciences' top insider investors include:
Gtcr Investment Xi Llc (Director)
Carl Hull (Insider)
Learn More about top insider investors at Maravai LifeSciences.
Who are the major institutional investors of Maravai LifeSciences?: Maravai LifeSciences' top institutional shareholders include:
Braidwell LP — 3.31%
Massachusetts Financial Services Co. MA — 1.43%
Jennison Associates LLC — 1.18%
FMR LLC — 0.98%
Glenmede Trust Co. NA — 0.88%
Charles Schwab Investment Management Inc. — 0.38%
Learn More about top institutional investors of Maravai LifeSciences stock.
Which major investors are selling Maravai LifeSciences stock?: Within the previous quarter, MRVI stock was sold by these institutional investors:
Jennison Associates LLC
Massachusetts Financial Services Co. MA
Braidwell LP
Principal Financial Group Inc.
Roubaix Capital LLC
FMR LLC
Connor Clark & Lunn Investment Management Ltd.
Algert Global LLC
Which major investors are buying Maravai LifeSciences stock?: Within the previous quarter, MRVI stock was purchased by institutional investors including:
Royce & Associates LP
Cannon Global Investment Management LLC
Charles Schwab Investment Management Inc.
E. Ohman J or Asset Management AB
Victory Capital Management Inc.
MetLife Investment Management LLC
SG Americas Securities LLC
Thrivent Financial for Lutherans